Subscribe to RSS
DOI: 10.1055/s-0028-1087383
Synthesis of 1-Methylbenzimidazoles from Carbonitriles
Publication History
Publication Date:
12 December 2008 (online)
![](https://www.thieme-connect.de/media/synlett/200901/lookinside/thumbnails/10.1055-s-0028-1087383-1.jpg)
Abstract
The NaH-mediated N-methylbenzimidazole formation starting from carbonitriles and N-methyl-1,2-phenylenediamine is reported to be a procedure compatible with acid-labile acetal protective groups within the starting materials. Products were further converted in Suzuki, Sonogashira, Heck and Buchwald-Hartwig reactions.
Key words
benzimidazoles - heterocycles - carbonitriles - cross-coupling
- 1
Horton DA.Bourne GT.Smythe ML. Chem. Rev. 2003, 103: 893 - 2
Janssens F.Janssen MAC.Awouters F.Niemegeers CJE.Vanden Bussche G. Drug Dev. Res. 1986, 8: 27 - 3
Mimran A.Alfaro V. Drugs Today 2003, 39: 439 - 4
Olbe L.Carlsson E.Lindberg P. Nat. Rev. Drug Discovery 2003, 2: 132 - 5
Eriksson BI.Smith H.Yasothan U.Kirkpatrick P. Nat. Rev. Drug Discovery 2008, 7: 557 -
6a
Preston PN. Chem. Rev. 1974, 74: 279 -
6b
Grimmett MR. In Science of Synthesis Vol. 12:Neier R. Thieme; Stuttgart: 2002. p.529 - 7
Duschmale JJ.Woltering TJ.Bleicher KH. Synlett 2008, 1467 - 8
Hölljes EL.Wagner EC. J. Org. Chem. 1944, 9: 31 -
9a
Haugwitz RD.Maurer BV.Jacobs GA.Narayanan VL.Cruthers L.Szanto J. J. Med. Chem. 1979, 22: 1113 -
9b
Renouard T.Grätzel M. Tetrahedron 2001, 57: 8145 -
9c
Renouard T.Fallahpour R.-A.Nazeeruddin MK.Humphry-Baker R.Gorelsky SI.Lever ABP.Grätzel M. Inorg. Chem. 2002, 41: 367 - 10
Nabulsi NAR.Gandour RD. J. Org. Chem. 1991, 56: 2260 -
12a
Muller G.Riehl JP.Schenk KJ.Hopfgartner G.Piguet C.Bünzli J.-CG. Eur. J. Inorg. Chem. 2002, 3101 -
12b
Dubey PK.Reddy PVVP.Srinivas K. Synth. Commun. 2007, 37: 1675 -
13a
Hey DH.Long RAJ. J. Chem. Soc. 1959, 2254 -
13b
Matsushita H.Lee S.-H.Joung M.Clapham B.Janda KD. Tetrahedron Lett. 2003, 45: 313 - 14
Elderfield RC.Meyer VB. J. Am. Chem. Soc. 1954, 76: 1891 - 15
Weidenhagen R.Train G.Wegner H.Nordström L. Ber. Dtsch. Chem. Ges. B 1942, 75: 1936 - 16
Sims HJ.Parseghian HB.de Benneville PL. J. Org. Chem. 1958, 23: 724 - 17
Schlosser M.Brich Z. Helv. Chim. Acta 1978, 61: 1903 -
18a
Wilfred CD.Taylor RJK. Synlett 2004, 1628 -
18b
Kuebel-Polak A.Rüttimann S.Dunn N.Melich X.Williams AF.Bernardinelli G. Helv. Chim. Acta 2006, 89: 841 -
18c
Algül Ö.Özcelik B.Abbasoglu U.Gümüs F. Turk. J. Chem. 2005, 29: 607 - 19
Chang C.-S.Lin Y.-T.Shih S.-R.Lee C.-C.Lee Y.-C.Tai C.-L.Tseng S.-N.Chern J.-H. J. Med. Chem. 2005, 48: 3522 - 20
Schareina T.Zapf A.Mägerlein W.Müller N.Beller M. Chem. Eur. J. 2007, 13: 6249 -
21a
Douhal A.Amat-Guerri F.Lillo MP.Acuna AU. J. Photochem. Photobiol., A 1994, 78: 127 -
21b
Fekner T.Gallucci J.Chan MK. Org. Lett. 2003, 5: 4795 -
22a
Sekine T.Higuchi Y.Yamada T.Murakoshi I. Chem. Pharm. Bull. 1989, 37: 1987 -
22b
Czerwieniec R.Kapturkiewicz A.Lipkowski J.Nowacki J. Inorg. Chim. Acta 2005, 358: 2701 - cataCXium FSulf = dicyclohexyl{2-sulfo-9-[3-(4-sulfo-phenyl)propyl]-9-fluorenyl}phosphonium hydrogensulfate; for use in Suzuki reactions, see:
-
24a
Fleckenstein CA.Plenio H. Green Chem. 2007, 9: 1287 -
24b
Fleckenstein CA.Plenio H. Chem. Eur. J. 2007, 13: 2701 - 28
Vinodkumar R.Vaidya SD.Kumar BVS.Bhise UN.Bhirud SB.Mashelkar UC. Eur. J. Med. Chem. 2008, 43: 986 -
29a
Meyer FE.Ang KH.Steinig AG.de Meijere A. Synlett 1994, 191 -
29b
Ang KH.Bräse S.Steinig AG.Meyer FE.Llebaria A.Voigt K.de Meijere A. Tetrahedron 1996, 52: 11503 -
29c
de Meijere A.Meyer FE. Angew. Chem., Int. Ed. Engl. 1994, 33: 2379 ; Angew. Chem. 1994, 106, 2473 - 31
Wolfe JP.Buchwald SL. J. Org. Chem. 2000, 65: 1144
References and Notes
2-Cyclohexyl-1-methyl-1
H
-benzimidazole
(3a)
Diamine 1 (244 mg, 2.00
mmol), NaH (80.0 mg, 60% dispersion in mineral oil, 2.00
mmol), and abs. toluene (1.0 mL) were successively added to nitrile 2a (218 mg, 2.00 mmol). The mixture was
stirred for 3 h at 120 ˚C in a tightly closed
reaction vial, then completely transferred on top of a column (SiO2),
and chromatographed (hexane-EtOAc, 1:1; R
f
= 0.32)
to give the title compound 3a (384 mg,
1.79 mmol, 90%) as a light brown solid, mp 102 ˚C
(lit.¹³a 104 ˚C). ¹H
NMR (500 MHz, CDCl3): δ = 1.30-1.48
(m,
3 H), 1.74-2.03 (m, 7 H), 2.84 (tt, J = 3.5, 11.6
Hz, 1 H), 3.74 (s, 3 H), 7.20-7.31 (m, 3 H), 7.72-7.77
(m, 1 H) ppm. ¹³C{¹H} NMR
(125 MHz, CDCl3): δ = 25.82
(CH2), 26.32 (2 CH2), 29.52 (CH3),
31.46 (2 CH2), 36.33 (CH), 108.80 (CH), 119.27 (CH),
121.66 (CH), 121.87 (CH), 135.64 (C), 142.55 (C), 159.00 (C) ppm.
IR (ATR): ν = 3173 (w), 3052 (w),
2929 (s), 2851 (m), 1730 (m), 1615 (m), 1506 (m), 1441 (s), 1278
(m), 1239 (m), 842 (m), 736 (s) cm-¹.
MS (EI, 70 eV): m/z (%) = 214
(14) [M+], 159 (100). HRMS
(CI, isobutane): m/z calcd for
C14H19N2: 215.1548; found: 215.1548 [M + H+].
Anal. Calcd for C14H18N2 (214.31):
C, 78.46; H, 8.47; N, 13.07. Found: C, 78.40; H, 8.55; N, 13.05.
1-Methyl-2-phenyl-1
H
-benzimidazole
(3h)
Diamine 1 (6.1 g, 50
mmol), NaH (2.0 g, 60% dispersion in mineral oil, 50 mmol)
and abs. mesitylene (10 mL) were successively added to nitrile 2h (5.2 g, 50 mmol). The mixture was heated
to reflux for 16 h (inner temp ca. 170 ˚C, oil
bath 210 ˚C). After cooling to ambient temperature,
the mixture was filtered through SiO2 (1 cm), the residue washed
with CH2Cl2 (5 mL), and the combined filtrates evaporated.
The residue was chromatographed (SiO2, hexane-EtOAc, 1:1; R
f
= 0.34)
to give the title compound 3a (6.2 g, 30
mmol, 60%) as a light yellow solid, mp 91 ˚C (lit.¹8b 92-93 ˚C). ¹³C{¹H} NMR
(125 MHz, CDCl3): δ = 31.57
(CH3), 109.54 (CH), 119.76 (CH), 122.33 (CH), 122.67
(CH), 128.58 (2 CH), 129.35 (2 CH), 129.63 (CH), 130.16 (C), 136.51
(C), 142.91 (C), 153.70 (C) ppm. All other data were in accordance
with the literature.¹8b
2-(Biphenyl-4-yl)-1-methyl-1
H
-benzimidazole
(4)
A mixture of bromophenyl compound 3i (91
mg, 0.32 mmol, 1.0 equiv), PhB(OH)2 (42 mg, 0.35 mmol,
1.1 equiv), Na2PdCl4 (1.2 mg, 4.2 µmol,
1.3 mol%), cataCXium Fsulf (3.3 mg, 4.5 µmol,
1.5 mol%), and K2CO3 (131 mg, 945 µmol,
3 equiv) was placed in a Schlenk tube and twice evacuated and flushed
with N2. Degassed H2O (0.5 mL) and BuOH (0.5
mL) were added, and the resulting mixture was stirred for 16 h at
100 ˚C. Subsequently, the organic layer was separated
and the aqueous layer extracted with CH2Cl2 (5
mL). The combined organic layers were dried (MgSO4), and
after filtration, the solvent was evaporated and the residue chromatographed
(SiO2, hexane-EtOAc = 1:1, R
f
= 0.48)
to give the title compound 4 (82 mg, 0.29 µmol, 92%)
as a yellow solid, mp 164 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 3.87
(s, 3 H), 7.29-7.34 (m, 2 H), 7.35-7.40 (m, 2
H), 7.46 (t, J = 7.6
Hz, 2 H), 7.62-7.67 (m, 2 H), 7.71-7.76 (m, 2
H), 7.81-7.87 (m, 3 H) ppm. ¹³C{¹H} NMR
(125 MHz, CDCl3): δ = 31.70
(CH3), 109.57 (CH), 119.75 (CH), 122.42 (CH), 122.74
(CH), 127.08 (2 CH), 127.26 (2 CH), 127.78 (CH), 128.86 (2 CH),
128.94 (C), 129.77 (2 CH), 136.61 (C), 140.09 (C), 142.40 (C), 142.93
(C), 153.40 (C) ppm. IR (ATR): ν = 3031
(w), 2925 (w), 1463 (m), 1375 (m), 1325 (m), 1005 (m), 850 (m),
765 (m), 737 (s), 690 (s) cm-¹. MS (EI,
70 eV): m/z (%) = 284
(98) [M+], 283 (100), 179
(10), 152 (10), 78 (12), 77 (29). HRMS (EI, 70 eV): m/z calcd for C20H16N2:
284.1313; found: 284.1313 [M+].
cataCXium FBu = (9-butyl-9-fluorenyl)dicyclohexylphos-phonium tetrafluoroborate; for use in Sonogashira reactions, see ref. 24a
27
1-Methyl-2-[4-(phenylethynyl)phenyl]-1
H
-benzimi-dazole
(5)
²8
A suspension of bromophenyl
compound 3i (91 mg, 0.32 mmol, 1 equiv),
phenylacetylene (38 mg, 0.38 mmol, 1.2 equiv), Na2PdCl4 (1.5
mg, 5.1 µmol, 1.6 mol%), cataCXium FBu (3.6 mg,
7.2 µmol, 2.3 mol%), and CuI (1.5 mg, 7.8 µmol,
2.5 mol%) in i-PrNH2 (1.0
mL) was stirred under an inert atmosphere for 16 h at 100 ˚C.
Subsequently, all volatile materials were removed in vacuo, the
residue dissolved in CH2Cl2 (5 mL), and washed
with H2O (2 ×
3 mL). The
organic layer was dried (Na2SO4), and after filtration,
the solvent was evaporated. Chromatography of the residue (SiO2;
hexane-EtOAc, 2:1; R
f
= 0.29)
gave the title compound 5 (81 mg, 0.26
mmol, 84%) as a light yellow solid, mp 152 ˚C
(lit.²8 153-155 ˚C). ¹H
NMR (500 MHz, CDCl3): δ = 3.80
(s, 3 H), 7.26-7.37 (m, 6 H), 7.50-7.57 (m, 2
H), 7.63-7.68 (m, 2 H), 7.71-7.77 (m, 2 H), 7.79-7.86
(m, 1 H) ppm. ¹³C{¹H} NMR
(125 MHz, CDCl3): δ = 31.63 (CH3),
88.71 (C), 91.27 (C), 109.58 (CH), 119.75 (CH), 122.47 (CH), 122.77
(C), 122.87 (CH), 124.62 (C), 128.31 (2 CH), 128.48 (CH), 129.20
(2 CH), 129.68 (C), 131.57
(2 CH), 131.70 (2 CH), 136.56
(C), 142.86 (C), 152.83 (C) ppm. IR (ATR): ν = 3058
(w), 2950 (w), 2216 (w), 1457 (m), 1437 (m), 1381 (m), 1329 (m),
1249 (m), 1103 (m), 1007 (m), 919 (m), 840 (s), 740 (s), 730 (s),
690 (s) cm-¹.
MS (EI, 70
eV): m/z (%) = 308
(100) [M+], 307 (80), 203 (23),
176 (12), 154 (12). HRMS (EI, 70 eV): m/z calcd
for C22H16N2: 308.1313; found:
308.1313 [M+].
(
E
)-1-Methyl-2-[4-(2-phenylethenyl)phenyl]-1
H
-benz-imidazole
(6)
A mixture of bromophenyl compound 3i (60
mg, 0.21 mmol, 1 equiv), freshly distilled styrene (44 mg, 0.42
mmol, 2.0 equiv), Pd(OAc)2 (5.0 mg, 21 µmol,
0.1 equiv), Ph3P (14 mg, 51 µmol, 0.24 equiv),
Et3N (85 mg, 0.84 mmol, 4.0 equiv), and abs. DMF (3.0
mL) was stirred for 16 h at 100 ˚C under an inert
atmosphere. Subsequently, all volatile materials were removed in
vacuo, the residue dissolved in CH2Cl2 (5 mL),
and washed with H2O (2 × 3
mL). The organic layer was dried (Na2SO4),
and after filtration, the solvent was evaporated. Chromatography
of the residue (SiO2; hexane-EtOAc, 2:1; R
f
= 0.27)
gave the title compound 6 (31 mg, 0.10
mmol, 48%) as a light yellow solid, mp 150 ˚C. ¹H NMR
(500 MHz, CDCl3): δ = 3.86
(s, 3 H), 7.15 (d, J = 16.3 Hz,
1 H), 7.21 (d, J = 16.3
Hz, 1 H), 7.23-7.34 (m, 3 H), 7.33-7.41 (m, 3
H), 7.50-7.56 (m, 2 H), 7.60-7.68 (m, 2 H), 7.72-7.79
(m, 2 H), 7.80-7.87 (m, 1 H) ppm. ¹³C{¹H} NMR (125
MHz, CDCl3): δ = 31.74
(CH3), 109.56 (CH), 119.74 (CH), 122.45 (CH), 122.76
(CH), 126.63 (4 CH), 127.67 (CH), 127.97 (CH), 128.71 (2 CH), 129.01
(C), 129.68
(2 CH), 130.17 (CH), 136.62 (C), 136.90 (C),
138.68 (C), 142.91 (C), 153.40 (C) ppm. IR (ATR): ν = 3025
(w), 2953 (w), 1461 (m), 1379 (m), 1326 (m), 960 (m), 821 (s), 741
(s), 688 (s) cm-¹. MS (EI, 70 eV): m/z (%) = 310
(100) [M+], 309 (75). HRMS
(EI, 70 eV): m/z calcd for C22H18N2:
310.1470; found: 310.1470 [M+].
2-[4-(Cyclohexylamino)phenyl]-1-methyl-1
H
-benzimi-dazole
(7)
A suspension of Pd(OAc)2 (3.0 mg, 11 µmol,
5.0 mol%) and rac-BINAP (7.0
mg, 11 µmol, 7.5 mol%) in abs. toluene (1.5 mL)
was stirred for 5 min at 23 ˚C under an inert
atmo-sphere. Bromophenyl compound 3i (60
mg, 0.21 mmol, 1 equiv), CyNH2 (27 mg, 0.27 mmol, 1.3
equiv), and NaOt-Bu (34 mg, 0.36 mmol,
1.7 equiv) were added, and the resulting mixture was stirred for
16 h at 85 ˚C. Subsequently, it was diluted with
CH2Cl2 (5 mL) and washed with sat. NaHCO3 solution
(5 mL). The organic layer was dried (MgSO4), and after
filtration, the solvent was evaporated. Chromatography of the residue
(SiO2; hexane-EtOAc, 1:2; R
f
= 0.44)
gave the title compound 7 (42 mg, 0.14
mmol, 65%) as a light yellow solid, mp 145 ˚C. ¹H
NMR (500 MHz, CDCl3): δ = 1.13-1.29
(m, 3 H), 1.32-1.46 (m, 2 H), 1.62-1.70 (m, 1
H), 1.73-1.83 (m, 2 H), 2.01-2.13 (m, 2 H), 3.25-3.39
(m, 1 H), 3.77-3.93 (m, 4 H), 6.63-6.69 (m, 2
H), 7.23-7.28 (m, 2 H), 7.29-7.34 (m, 1 H), 7.54-7.60
(m, 2 H), 7.74-7.80 (m, 1 H) ppm. ¹³C{¹H} NMR
(125 MHz, CDCl3): δ = 24.89
(2 CH2), 25.78 (CH2), 31.74 (CH3),
33.24 (2 CH2), 51.40 (CH), 109.23 (CH), 112.51 (2 CH),
117.80 (C), 119.20 (CH), 121.97 (CH), 122.00 (CH), 130.65 (2 CH),
136.61 (C), 142.97 (C), 148.49 (C), 154.62 (C) ppm. IR (ATR): ν = 3335
(w), 3055 (w), 2928 (m), 2853 (m), 1608 (s), 1542 (m), 1456 (s),
1379 (m), 1323 (m), 1180 (m), 1006 (m), 888 (s), 828 (m), 814 (m),
743 (s), 731 (s) cm-¹. MS (EI, 70 eV): m/z (%) = 305 (100) [M+],
304 (16), 263 (12), 262 (62), 222 (14), 131 (10). HRMS (EI, 70 eV): m/z calcd for C20H23N3:
305.1892; found: 305.1892 [M+].